Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus
To browse Podcasts by topic, please visit the new Cochrane Summaries site here
The beneficial effects of insulin for type 1 diabetes are dramatic, and didn’t require proof from randomised trials. However, trials and reviews are needed to compare the effects of different different modalities of insulin delivery. Marie Misso and colleagues in Melbourne, Australia have done such a review.
Play Now!
Download [mp3]
| Read Review
Updated on: June 20, 2011, 13:33
Copyright © The Cochrane Collaboration
Comments for improvement or correction are welcome.
Email: web@cochrane.org



